Oxford Events, the new replacement for OxTalks, will launch on 16th March. From now until the launch of Oxford Events, new events cannot be published or edited on OxTalks while all existing records are migrated to the new platform. The existing OxTalks site will remain available to view during this period.
From 16th, Oxford Events will launch on a new website: events.ox.ac.uk, and event submissions will resume. You will need a Halo login to submit events. Full details are available on the Staff Gateway.
Dr Hellner attended medical school in Germany and holds a medical PhD. Her postdoctoral research at Harvard Medical School focussed on the discovery of novel therapeutics for HPV associated cancers. She joined Oxford University 12 years ago as a clinical lecturer. After completing her clinical training in obstetrics & gynaecology, she was appointed as Senior Fellow in Women’s Health. She is an honorary consultant gynaecologist at OUH and leads the trust’s colposcopy department. Her research aims at utilizing the body’s immune system to fight persistent infections with HPV and precancers. She is the Chief-investigator for the first in-human trial of a therapeutic vaccine that was developed in Oxford.
Please email Louise King (louise.king@nds.ox.ac.uk) if you would like to attend online.
